Work

Emicizumab Prophylaxis in Adolescent/Adult Patients with Hemophilia A Previously Receiving Episodic or Prophylactic Bypassing Agent Treatment: Updated Analyses from the HAVEN 1 Study

Year: 2017

Type: article

Source: Blood

DOI: 10.1182/blood.v130.suppl_1.1071.1071

Authors: Maria Elisa Mancuso, Michael U. Callaghan, Rebecca Kruse‐Jarres, Christine L. Kempton, Jin Xu, Olivier Catalani, Elina Asikanius, Gallia G. Levy, Midori Shima, Guy Young, Johannes Oldenburg

Institutions: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Detroit Medical Center, Children's Hospital of Michigan, University of Washington, Bloodworks Northwest, Emory University, Genentech, F. Hoffmann-La Roche AG, Nara Medical University, University of Southern California, Children's Hospital Los Angeles, University Hospital Bonn

Language: English

Topic: Hemophilia Treatment and Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3021441237

FWCI: 1.9

Cites:

Cited by: 18

Related to: 10